Cited by 263RNA Research and SplicingNeuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2

Open access
Zheng, Sika, Gray, Erin E, Chawla, Geetanjali, Porse, Bo Torben, O'Dell, Thomas J, Black, Douglas L·2012·Nature Neuroscience

Abstract

Postsynaptic density protein 95 (PSD-95) is essential for synaptic maturation and plasticity. Although its synaptic regulation has been widely studied, the control of PSD-95 cellular expression is not understood. We found that Psd-95 was controlled post-transcriptionally during neural development. Psd-95 was transcribed early in mouse embryonic brain, but most of its product transcripts were degraded. The polypyrimidine tract binding proteins PTBP1 and PTBP2 repressed Psd-95 (also known as Dlg4) exon 18 splicing, leading to premature translation termination and nonsense-mediated mRNA decay. The loss of first PTBP1 and then of PTBP2 during embryonic development allowed splicing of exon 18 and expression of PSD-95 late in neuronal maturation. Re-expression of PTBP1 or PTBP2 in differentiated neurons inhibited PSD-95 expression and impaired the development of glutamatergic synapses. Thus, expression of PSD-95 during early neural development is controlled at the RNA level by two PTB proteins whose sequential downregulation is necessary for synapse maturation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.3026

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The highest enrichment was observed in developing brain, germinal matrix, cortex-derived neurospheres, and ESC-derived neurons, consistent with ASD as a neurodevelopmental disorder with largely prenatal origins.

    “The highest enrichment was observed in the developing brain, germinal matrix, cortex-derived neurospheres, and embryonic stem cell (ESC)-derived neurons, consistent with ASD as a neurodevelopmental disorder with largely prenatal origins, as supported by data from analysis of rare de novo variants 76 .”

    From Identification of common genetic risk variants for autism spectrum disorder (2019) · cites this paper as [76]

    The Results section (‘Psd-95 mRNA is actively transcribed but lost to AS-NMD’; page unavailable) examines PSD-95 regulation in developing brain and cortical neurons, not enrichment across the listed tissues and cell types. Searches for germinal matrix, neurospheres, ESC-derived neurons, ASD, and rare de novo variants found no passage addressing the attributed enrichment or prenatal-origin claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Both common and rare variation in ASD preferentially affects genes expressed during corticogenesis, highlighting a potential spatiotemporal convergence of genetic risk on this developmental epoch.

    “Interestingly, both common and rare variation in ASD preferentially affects genes expressed during corticogenesis 76 , highlighting a potential spatiotemporal convergence of genetic risk on this specific developmental epoch, despite the disorder's profound genetic heterogeneity.”

    From Identification of common genetic risk variants for autism spectrum disorder (2019) · cites this paper as [76]

    The Results passage on primary cortical cultures describes developmental regulation of PSD-95 by PTBP1 and PTBP2, not the distribution of ASD genetic risk. Searches for common and rare ASD variation and for genetic risk during corticogenesis found no passage addressing the attributed claim. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • Overexpression of either PTBP1 or PTBP2 in mature neurons inhibits exon 18 inclusion, PSD95 protein expression and excitatory synapse formation.

    “Overexpression of either PTBP1 or PTBP2 in mature neurons inhibits exon 18 inclusion, PSD95 protein expression and excitatory synapse formation67.”

    From The neurogenetics of alternative splicing (2016) · cites this paper as [67]

  • High expression of PTBP2 during early development extends the expression of the embryonic splicing programme until late in neuronal maturation.

    “Thus the high expression of PTBP2 during early development extends the expression of the embryonic splicing programme until late in neuronal maturation.”

    From The neurogenetics of alternative splicing (2016) · cites this paper as [67]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zheng, S., Gray, E. E., Chawla, G., Porse, B. T., O'Dell, T. J., & Black, D. L.
Affiliations
  • Howard Hughes Medical Institute (US)
  • University of California, Los Angeles (US)
  • University of Copenhagen (DK)
Corresponding author
Black, Douglas L
Venue
Nature Neuroscience
Published
2012-01-15
Volume
15
Issue
3
Pages
381-388
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2026441189
Cited by
254
References
50
Citations by year
2026: 9 · 2025: 19 · 2024: 29 · 2023: 18 · 2022: 14 · 2021: 21 · 2020: 15 · 2019: 14 · 2018: 21 · 2017: 14 · 2016: 18 · 2015: 18 · 2014: 19 · 2013: 20 · 2012: 5
FWCI
7.92
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Lundbeckfonden (R5-2006-99)
  • National Institute of Mental Health (F32 MH84562, R01MH060919, F31MH085462)
  • National Institute of General Medical Sciences (R01GM049662)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
PSD-95, PTBP1, PTBP2, polypyrimidine tract-binding protein, alternative splicing, nonsense-mediated mRNA decay, post-transcriptional regulation, synapse maturation, glutamatergic synapses, neuronal maturation, embryonic brain development
MeSH terms
Disks Large Homolog 4 Protein, Empty Spiracles Homeobox Proteins, Age Factors, Animals, Carrier Proteins, Cell Differentiation, Cells, Cultured, Cerebral Cortex, Dendrites, Electric Stimulation, Embryo, Mammalian, Exons, Hippocampus, Membrane Proteins, Mice, Transgenic, Neuroblastoma, Neurons, RNA Splicing, RNA, Messenger, Transcription Factors, Transfection, RNA-Binding Proteins, Homeodomain Proteins, Patch-Clamp Techniques, Gene Expression Regulation, Developmental, Excitatory Postsynaptic Potentials, Electrophoretic Mobility Shift Assay, RNA, Small Interfering, Polypyrimidine Tract-Binding Protein, Green Fluorescent Proteins, Mice, Guanylate Kinases, Neurogenesis, Neural Stem Cells, RNA Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review